Catalyst Pharmaceuticals (CPRX) soared 19% after a report that Italian drugmaker Angelini Pharma is evaluating a potential purchase of the drugmaker. Angelini is working with advisers as it evaluates ...

We just covered the Billionaire Joe Edelman’s 10 Stock Picks with Huge Upside Potential and Praxis Precision Medicines, Inc. (NASDAQ:PRAX) ranks 1st on this list. Praxis Precision Medicines, Inc.

With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...

Italy's Angelini Pharma has agreed to buy Catalyst Pharma of the US for up to $4.1 billion, saying the deal is a "pivotal moment" in its 100-year-plus history. Privately held Angelini will pay $31.50 ...

Musely, a direct-to-consumer telemedicine platform, has secured over $360 million in non-dilutive capital from General Catalyst’s Customer Value Fund (CVF). The company specializes in compounded ...

Angelini Pharma has agreed to acquire all outstanding shares of Catalyst Pharmaceuticals (CPRX) for $31.50 per share in cash, for a total equity value of approximately $4.1B. The deal has been ...

Rare-disease specialist Catalyst Pharmaceuticals is set to be acquired by healthcare group Angelini Pharma in a $4.1 billion deal. Angelini will pay $31.50 for each of Nasdaq-listed Catalyst’s ...

Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.

The number of people who got laid off in the first four months of the year, according to outplacement firm Challenger, Gray & Christmas. That is 50% lower than the same period last year, when massive ...